Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. (FRX.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FRX.TO · as of Jun 8, 2026
Key Statistics
Explore Fennec Pharmaceuticals Inc. Data
frx.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 100.0%
Competitors & Peers
frx.to competitorsFRX.TO
CYBN.NE
DR.TO
EPRX.TO
HBP.TO
HITI.VStock Performance
Full HistoryAbout Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. a biopharmaceutical firm established in 1996, operates from its base in Research Triangle Park, North Carolina. The company's lead investigational compound, PEDMARK, is a …
what is fennec pharmaceuticals inc. · frx.to stock overview · fennec pharmaceuticals inc. company profile · who is fennec pharmaceuticals inc. ceo · frx.to TSX · fennec pharmaceuticals inc. headquarters · fennec pharmaceuticals inc. business segments
About Stock Overview & Key Data
Fennec Pharmaceuticals Inc. (FRX.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Jun 12, 2001. As of the latest trading session, FRX.TO stock price is $12.44, with a market capitalization of $355.5M. The stock has returned +5.04% over the past 12 months and +20.00% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Fennec Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Fennec Pharmaceuticals Inc. reported revenue of $45.4M and net income of -$10.3M. For detailed data — including Fennec Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Fennec Pharmaceuticals Inc. (FRX.TO) stock price is $12.44. The stock is traded on TSX under the ticker symbol FRX.TO. The 52-week range is $7.59 – $14.24.